Refine Results
- 必威体育赛事投注
- Content Type
- Analysis Platform
- Language
1 - 13 of 13 results
Applied Filters
必威体育登录手机This application note describes how the Agilent BioTek 406 FX washer dispenser increases a laboratory's efficiency and productivity by automating the liquid handling steps of the CellTiter-GLO assay.
必威体育登录手机Cellular-resolution Agilent Seahorse XF bioenergetic analyses were combined with molecular-resolution Agilent Revident Q-TOF LC/MS to investigate adaptations in cancer cells.
User Guide for SureSelect Cancer CGP Assay and SureSelect Cancer Tumor-specific Assays.
必威体育登录手机This application note highlights the wide range in instrumentation, plastics, and reagents that Agilent offers to enable a complete workflow for cell-based toxicity assays.
This application note demonstrates the signal recording of the xCELLigence RTCA eSight, enabling visualization and quantification of cell migration and invasion and the speed of wound closure healing.
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
Protocol for SureSelect XT HS2 DNA Kits for Library Prep (+/-MBC) and Target Enrichment (Fast/Overnight Hyb), Automated using NGS Workstation Option B
必威体育登录手机This flyer provides and overview of the family of Agilent SureSelect Community Designs designed by scientists in the Adam's Group at the Wellcome Sanger Institute.The aim of the research is to understand the genetics of cancer, using a combination...
This study investigates the impact of Wnt-signaling modulators on mitochondrial dysfunction.It evaluates the effects of selected drug treatments on cellular energy metabolism and cytotoxicity by comparing two distinct breast cancer cell lines: one...
This poster outlines combining the 3D tumor spheroid invasion model with the RTCA eSight's capability of live cell imaging and automatic quantification of the area of invasive protrusion can facilitate and enhance the development of new treatments...
必威体育登录手机Customize insights for tumor genomic profiling by adding new and emerging biomarkers, including TMB and MSI, with Agilent SureSelect Cancer Custom panels.必威体育登录手机Fast and easy panel design with Agilent SureDesign.
PD-L1 IHC 22C3 pharmDx (SK006) is a qualitative immunohistochemical (IHC) assay using anti-PD-L1, Clone 22C3, to detect PD-L1 in formalin-fixed, paraffin-embedded (FFPE) tumor tissues using the Autostainer Link 48.
In the present study, we present a simple metabolic preconditioning process that improves T-cell performance and bioenergetics.